Editorial, 03 | DOI: 10.53260/grem.201011


Dear Colleagues and Friends,

In March 1987, I had the honor of writing the editorial for the first issue of Gynecological Endocrinology, the official journal of the International Society of Gynecological Endocrinology (ISGE), initially published by David Bloomer, the owner of Parthenon Publishing. I have always strongly believed in the importance of promoting women’s health, and at that time it was my dream to bring to life a journal entirely devoted to this area. David Bloomer, who very much supported the idea, greatly contributed to the realization of that dream.

Gynecological Endocrinology, currently published by Taylor and Francis, has now reached its 36th volume; last year, 760 manuscripts were submitted to the journal and 230 articles were published in the 35th volume. These statistics clearly illustrate the success of the journal’s mission, and underline its importance and value within the community of scientists interested in gynecological endocrinology.

Now, in March 2020, it is my pleasure and honor to introduce GREM – Gynecological and Reproductive Endocrinology and Metabolism, another official publication of the ISGE, this time an open-access journal directly produced by the Society. The launch of GREM clearly demonstrates how our area of interest has expanded towards reproductive and metabolic aspects of gynecological endocrinology.

The decision to make GREM an open-access journal was taken in order to facilitate its accessibility to our readers and to amplify its impact within the scientific community.

The aim of GREM is to promote research in a range of fields: gynecology, obstetrics, reproduction, feto-maternal  medicine, basic science, pharmacology, epidemiology, metabolism, oncology, neuro-endocrinology, psychosomatic medicine, sexology, female aging, ethics, and quality of life, as well as research relevant to any other aspects of gynecological and reproductive endocrinology and metabolism.

As gynecological and reproductive endocrinology comprises a vast range of topics, particular attention and appreciation will be given to submissions related to: endocrine therapies in women, puberty, adolescent gynecology, contraception, fertility, polycystic ovary syndrome, endometriosis, assisted reproduction, abortion, eclampsia, gestational diabetes mellitus, premature labor, breastfeeding, premature ovarian insufficiency, menopause, female sexual dysfunction, osteoporosis, GSM/VVA, and gynecological cancers.

The article types published in GREM are: editorials, statements, position papers, systematic reviews, meta-analyses, short reviews, original articles and case reports.

The likely impact and importance of GREM is plainly reflected in the content of this issue which comprises 3 reviews, 1 short review, and 8 original articles.

The journal is published quarterly. In addition, subject to the approval of the Editorial Committee, peer-reviewed supplements may also be published.

As Supplement n. 1 you will find the Abstract Book of the 19th World Congress of Gynecological  Endocrinology (Florence, March  4th – 7th 2020), which contains all the submitted, reviewed and accepted abstracts relating to the keynote lectures, “Meet the Expert” sessions, symposia (including symposia organized by  scientific societies), oral presentations, posters and sponsored sessions scheduled to take place during our 2020 biannual  congress.

I am convinced that GREM will prove to be, for all students, trainees, clinicians and scientists, a valuable opportunity to learn about or keep up-to-date with the scientific discoveries related to the areas of gynecology, obstetrics and reproductive medicine.

On behalf of all the members of the Editorial Board is my privilege to invite you to submit your manuscripts to GREM, the new open-access journal of the International Society of Gynecological Endocrinology.

Citation: Genazzani A., Editorial, GREM Gynecological and Reproductive Endocrinology & Metabolism (2020); 01/2020:03 doi: 10.53260/grem.201011

Published: February 16, 2020